«Ganglioneuroma

Below is an extended Ganglioneuroma patents listing. Click here to return to the Ganglioneuroma main in depth entry.

Patents :
US Patent No.	Title
6365362	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6569638	Method for screening compounds for the treatment of neoplasia
6610835	Sphingolipid derivatives and their methods of use
6610839	Promoter for telomerase reverse transcriptase
6617110	Cells immortalized with telomerase reverse transcriptase for use in drug screening
6645731	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6656684	Method for predicting tumor recurrence
6667156	Diagnosis and treatment of neuroectodermal tumors
6689803	Compositions and methods for treating surgical adhesions
6846841	Anti-angiogenic compositions and methods of use
6849719	Antibody to an IL-17 receptor like protein
6555547	Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
6551774	Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity
6544544	Anti-angiogenic compositions and methods of use
6368789	Screening methods to identify inhibitors of telomerase activity
6391554	Detecting cancerous conditions by assaying for telomerase activity
6475789	Human telomerase catalytic subunit: diagnostic and therapeutic methods
6495579	Method for treating multiple sclerosis
6500610	Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds
6500938	Composition for the detection of signaling pathway gene expression
6506411	Anti-angiogenic compositions and methods of use
6506559	Genetic inhibition by double-stranded RNA
6515016	Composition and methods of paclitaxel for treating psoriasis
6524799	DNA encoding sparc-related proteins
6881542	Serine threonine kinase member, h2520-59
6893867	Molecular switch for regulating mammalian gene expression
7241769	Pyrimidines as PLK inhibitors
7250394	Treatment of glial tumors with glutamate antagonists
7262288	Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7276241	Methods of treating a tumor that expresses APRIL by administering BCMA
7304036	Methods and compositions for the treatment of gastrointestinal disorders
7307065	2'-Fluoronucleosides
7332288	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7371727	Methods and compositions for the treatment of gastrointestinal disorders
7393642	Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome
7413864	Treating cancer using a telomerase vaccine
7238492	Method for predicting tumor recurrence
7232805	Cobalamin conjugates for anti-tumor therapy
7205275	Methods of treatment using specific binding agents of human angiopoietin-2
6911424	2'-fluoronucleosides
6960559	Neurite growth regulatory factors
7029892	Serine threonine kinase member, h2520-59
7041786	Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
7071158	Antioxidant enhancement of therapy for hyperproliferative conditions
7078491	Selective binding agents of telomerase
7138370	Specific binding agents of human angiopoietin-2
7151162	Nuclear protein
7195911	Mammalian cells that have increased proliferative capacity
7199234	Regulatory segments of the human gene for telomerase reverse transcriptase
7427490	Diagnostic markers of stroke and cerebral injury and methods of use thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.